18 results
Cardiovascular and renal effects comparison between SGLT-2 inhibitors
 - Canagliflozin (Invokana)
 - Dapagliflozin (Farxiga)
 - Empagliflozin
Cardiovascular and renal ... comparison between SGLT ... (Steglatro) #diabetes ... #SGLT2i #Inhibitors ... #pharmacology
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
recommendations in renal ... hypoglycaemic agents #Diabetes ... #Diabetic #Medications ... #Pharmacology # ... Renal #Impairment
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
- Pharmacology ... of use) Common Side ... • Euglycemic diabetic ... #Inhibitors #Pharmacology ... #Summary #DM2 #diabetes
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
SGLT2 Inhibitors ... SGLT2 inhibitors ... class of anti-diabetic ... #Inhibitors #Pharmacology ... Medications #DM2 #Diabetes
TACROLIMUS - Side Effects Mnemonic

Tremor 
Alopecia 
Cardiovascular (HTN) 
Renal insufficiency 
Oncologic (Skin Cancer) 
Lipids (hyperlipidemia) 
Insulin
TACROLIMUS - Side ... Cardiovascular (HTN) Renal ... Insulin dependent diabetes ... Seizures #Pharmacology
Metformin 
Current Renal Dose Adjustments due to Risk of Lactic Acidosis 
> 60 No adjustment 
45-60
Metformin Current Renal ... #Metformin #Renal ... #Dosing #Dose # ... Pharmacology #Diabetes
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... receptor agonist, SGLT2i ... insulin in Type 1 Diabetes ... insulin dose for renal ... #Medications #pharmacology
Algorithm for Metformin Prescribing and Dosing in CKD
Dose Initiation - Immediate release:
 • Initial 500 mg
Prescribing and Dosing ... release: • If Gl side ... #Prescribing #Dosing ... #CKD #pharmacology ... #algorithm #diabetes
Metformin: Biguanide
Metformin is the first-line medication for treatment of type 2 diabetes. It is very effective
treatment of type 2 diabetes ... 2000 mg/day) and using ... attention to patients renal ... #Metformin #Pharmacology ... #Mechanism #Diabetes
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Inhibitors - Normal and Renal ... Dosing Increase ... with only few side ... #Dosing #Pharmacology ... #Management #Diabetes